1. A novel chalcone derivative suppresses melanoma cell growth through targeting Fyn/Stat3 pathway.
   Ling Tang et al, 2020, Cancer Cell Int CrossRef
2. The pleiotropic role of circular and long noncoding RNAs in cutaneous melanoma
   Barbara Montico et al, 2021, Mol Oncol CrossRef
3. Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness
   Ana Tadijan et al, 2021, Cancers CrossRef
4. Jug-PLGA-NPs, a New Form of Juglone with Enhanced Efficiency and Reduced Toxicity on Melanoma
   Wu-heng Yue et al, 2021, Chin. J. Integr. Med. CrossRef
5. Molecular biological mechanism of action in cancer therapies: Juglone and its derivatives, the future of development
   Yu Ting Tang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
6. Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies
   Wenda Wu et al, 2022, Pharmacological Research CrossRef
7. Naphthoquinone Derivatives Targeting Melanoma
   Jéssica Alves Nunes et al, 2023, CTMC CrossRef
8. Diclofenac Enhances the Response of BRAF Inhibitor to Melanoma Through ROS/p38/p53 Signaling
   Haihong Qin et al, 2025, Clin Exp Pharma Physio CrossRef